Related Experiment Video
Updated: May 7, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL
Belinda A Di Bartolo1, Siân P Cartland, Hanis H Harith
1Centre for Vascular Research, University of New South Wales, Sydney, NSW, Australia.
Insights
TNF-related apoptosis-inducing ligand (TRAIL) deficiency accelerates vascular calcification and cartilaginous metaplasia in atherosclerosis. TRAIL regulates receptor activator of nuclear factor-κB ligand (RANKL) and inflammatory markers involved in vascular bone turnover.
Area of Science:
- Vascular Biology
- Bone Homeostasis
- Atherosclerosis Research
Background:
- The osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand (RANKL) system regulates bone homeostasis and vascular calcification.
- TNF-related apoptosis-inducing ligand (TRAIL) is a second OPG ligand with an unestablished role in vivo vascular calcification.
Purpose of the Study:
- To investigate the role of TRAIL in vascular calcification in vitro and in vivo.
- To examine the involvement of OPG and RANKL in TRAIL-mediated vascular calcification.
Main Methods:
- In vitro studies used vascular smooth muscle cells (VSMCs) from TRAIL(-/-) and wild-type mice.
- In vivo studies utilized TRAIL(-/-)ApoE(-/-) mice with advanced atherosclerotic lesions.
- Analysis included calcium-induced calcification, gene expression (RANKL, OPG, TRAIL, collagen II, BMP-2, IL-1β, PPAR-γ), and histological assessment.
Main Results:
- TRAIL inhibited calcium-induced calcification in human VSMCs; TRAIL(-/-) VSMCs showed accelerated calcification.
- TRAIL deficiency in mice led to increased chondrocyte-like cells, collagen II, RANKL, BMP-2, IL-1β, and PPAR-γ expression in atherosclerotic lesions.
- Significant increases in vascular calcification were observed in TRAIL(-/-)ApoE(-/-) mice.
Conclusions:
- TRAIL deficiency accelerates cartilaginous metaplasia and vascular calcification in atherosclerosis.
- TRAIL plays a crucial role in regulating RANKL and inflammatory mediators of vascular bone turnover.
Abstract:
The osteoprotegerin (OPG) and receptor activator of nuclear factor-κB ligand (RANKL) cytokine system, not only controls bone homeostasis, but has been implicated in regulating vascular calcification. TNF-related apoptosis-inducing ligand (TRAIL) is a second ligand for OPG, and although its effect in vascular calcification in vitro is controversial, its role in vivo is not yet established. This study aimed to investigate the role of TRAIL in vascular calcification in vitro using vascular smooth muscle cells (VSMCs) isolated from TRAIL(-/-) and wild-type mice, as well as in vivo, in advanced atherosclerotic lesions of TRAIL(-/-)ApoE(-/-) mice. The involvement of OPG and RANKL in this process was also examined. TRAIL dose-dependently inhibited calcium-induced calcification of human VSMCs, while TRAIL(-/-) VSMCs demonstrated accelerated calcification induced by multiple concentrations of calcium compared to wild-type cells. Consistent with this, RANKL mRNA was significantly elevated with 24 h calcium treatment, while OPG and TRAIL expression in human VSMCs was inhibited. Brachiocephalic arteries from TRAIL(-/-)ApoE(-/-) and ApoE(-/-) mice fed a high fat diet for 12 w demonstrated increased chondrocyte-like cells in atherosclerotic plaque, as well as increased aortic collagen II mRNA expression in TRAIL(-/-)ApoE(-/-) mice, with significant increases in calcification observed at 20 w. TRAIL(-/-)ApoE(-/-) aortas also had significantly elevated RANKL, BMP-2, IL-1β, and PPAR-γ expression at 12 w. Our data provides the first evidence that TRAIL deficiency results in accelerated cartilaginous metaplasia and calcification in atherosclerosis, and that TRAIL plays an important role in the regulation of RANKL and inflammatory markers mediating bone turn over in the vasculature.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Regulation of Angiogenesis and Blood Supply
Inflammation
Peripheral Artery Disease I: Introduction

